Rankings
▼
Calendar
VRCA Q1 2025 Earnings — Verrica Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
VRCA
Verrica Pharmaceuticals Inc.
$56M
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
-10.1% YoY
Gross Profit
$3M
87.7% margin
Operating Income
-$8M
-236.4% margin
Net Income
-$10M
-283.3% margin
EPS (Diluted)
$-1.03
QoQ Revenue Growth
+899.7%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$42M
Total Liabilities
$61M
Stockholders' Equity
-$19M
Cash & Equivalents
$30M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3M
$4M
-10.1%
Gross Profit
$3M
$3M
+12.2%
Operating Income
-$8M
-$19M
+56.3%
Net Income
-$10M
-$20M
+52.1%
Revenue Segments
Product
$3M
100%
Collaboration
$17,000
0%
← Q4 2024
All Quarters
Q2 2025 →